Get the Stockscreener App
25.30
1.35%
0.3298
Privia Health Group Inc stock is traded at $25.30, with a volume of 551.95K.
It is up +1.35% in the last 24 hours and up +10.51% over the past month.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
See More
Previous Close:
$24.97
Open:
$24.83
24h Volume:
551.95K
Relative Volume:
0.91
Market Cap:
$2.99B
Revenue:
$1.72B
Net Income/Loss:
$12.82M
P/E Ratio:
253.00
EPS:
0.1
Net Cash Flow:
$98.59M
1W Performance:
+3.25%
1M Performance:
+10.51%
6M Performance:
+31.19%
1Y Performance:
+13.38%
1-Day Range:
$24.45
$25.34
1-Week Range:
$23.95
$26.04
52-Week Range:
$15.92
$26.04
Privia Health Group Inc Stock (PRVA) Company Profile
Name
Privia Health Group Inc
Sector
Industry
Phone
571-366-8850
Address
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
25.32 | 2.99B | 1.72B | 12.82M | 98.59M | 0.10 |
|
VEEV
Veeva Systems Inc
|
222.43 | 35.98B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
81.58 | 13.98B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
70.11 | 12.92B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.51 | 9.36B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
109.55 | 9.34B | 1.15B | 96.70M | -161.99M | 1.09 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-16-24 | Initiated | Macquarie | Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Feb-22-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-03-23 | Initiated | Goldman | Buy |
| Dec-09-22 | Initiated | Stifel | Buy |
| Dec-08-22 | Initiated | UBS | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| May-03-22 | Initiated | BofA Securities | Buy |
| Apr-28-22 | Initiated | BTIG Research | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Feb-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-03-22 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| May-24-21 | Initiated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Credit Suisse | Outperform |
| May-24-21 | Initiated | JP Morgan | Overweight |
| May-24-21 | Initiated | Piper Sandler | Overweight |
| May-24-21 | Initiated | Truist | Buy |
| May-24-21 | Initiated | William Blair | Outperform |
View All
Privia Health Group Inc Stock (PRVA) Latest News
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $30.00 - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $40.00 - Defense World
Leerink Partnrs Has Pessimistic View of PRVA Q1 Earnings - Defense World
Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $25.19 - MarketBeat
Versor Investments LP Acquires New Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2024 Earnings Call Transcript - MSN
JMP raises Privia Health stock target to $29 on strong outlook - Investing.com Canada
Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Taking on analysts’ expectations and winning: Privia Health Group Inc (PRVA) - SETE News
Truist Adjusts Price Target on Privia Health Group to $30 From $27, Maintains Buy Rating - Marketscreener.com
Canaccord lifts Privia Health stock target to $30, maintains Buy - Investing.com
JMP raises Privia Health stock target to $29 on strong outlook By Investing.com - Investing.com South Africa
Privia Health: Q4 Earnings Snapshot - The Herald Review
Rhumbline Advisers Grows Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group’s Strong Performance and Promising Outlook Justifies Buy Rating - TipRanks
Privia Health’s 2024 Earnings Call Highlights Growth - TipRanks
Citi raises Privia Health target to $32, maintains Buy rating By Investing.com - Investing.com Australia
Piper Sandler raises Privia Health stock target to $40 By Investing.com - Investing.com Canada
Piper Sandler raises Privia Health stock target to $40 - Investing.com India
Privia Health stock target raised to $30 by TD Cowen - Investing.com Canada
Citi raises Privia Health target to $32, maintains Buy rating - Investing.com India
Privia Health stock hits 52-week high at $24.16 amid growth - MSN
Privia Health Group rises on quarterly revenue growth - TradingView
Privia Health shares surge 7% on strong Q4 earnings beat - Investing.com India
Privia Health stock hits 52-week high at $25.73 amid growth - Investing.com Australia
Privia Health shares surge 7% on strong Q4 earnings beat By Investing.com - Investing.com Canada
Privia Health stock hits 52-week high at $25.73 amid growth By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q4 2024 beats earnings forecast - Investing.com
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings - Yahoo Finance
Privia Health Group, Inc. SEC 10-K Report - TradingView
Privia Health Group earnings beat by $0.16, revenue topped estimates - Investing.com Canada
Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations - Investing.com Canada
Privia Health shares slip over 2% as 2025 guidance falls short - Investing.com Canada
Privia Health shares slip over 2% as 2025 guidance falls short By Investing.com - Investing.com South Africa
Privia Health (PRVA) Lags Q4 Earnings Estimates - Yahoo Finance
Earnings Flash (PRVA) Privia Health Group Reports Q4 Revenue $460.9M, vs. FactSet Est of $420.8M - Marketscreener.com
Earnings Flash (PRVA) Privia Health Group Reports Q4 Adjusted EPS $0.21 -February 27, 2025 at 06:26 am EST - Marketscreener.com
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView
How Did Privia Health Generate 121% Free Cash Flow to EBITDA in Latest Earnings? - StockTitan
Privia Health Group Reports Strong 2024 Financial Results - TipRanks
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For By Stock Story - Investing.com Canada
Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Seeking Clues to Privia Health (PRVA) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Principal Financial Group Inc. Sells 174,389 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Hits New 52-Week HighShould You Buy? - MarketBeat
Privia Health Group (PRVA) Projected to Post Quarterly Earnings on Thursday - Defense World
(PRVA) Technical Pivots with Risk Controls - Stock Traders Daily
Privia Health's SWOT analysis: stock's steady growth amid healthcare challenges - MSN
Privia Health Group Inc Stock (PRVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.70%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):